In English
NIDA

El VIH/SIDA

Referencias

  1. Royce RA, Sena A, Cates W Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med 336(15):1072-1078, 1997.
  2. Gavrilin MA, Mathes LE, Podell M. Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J Neurovirol 8(3):240-249, 2002.
  3. Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E; HIV Neurobehavioral Research Center Group. Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr 34(5):467-474, 2003.
  4. Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I; HNRC Group. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 10(1):1 14, 2004.
  5. Woody GE, Gallop R, Luborsky L, Blaine J, Frank A, Salloum IM, Gastfriend D, Crits-Christoph P; Cocaine Psychotherapy Study Group. HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study. J Acquir Immune Defic Syndr. 33(1):82-87, 2003.
  6. McArthur JC. HIV dementia: An evolving disease. J Neuroimmunol 157(1-2):3-10, 2004.
  7. National Center for Infectious Diseases. Viral Hepatitis C Fact Sheet, 2004. CDC, 2005. Disponible en la página: http://www.cdc.gov/ncidod/diseases/hepatitis/c/fact.htm.
  8. Romeo R, Rumi MG, Donato MF, Carnel MA, Vigano P, Mondelli M, Cesana B, Colombo M. Hepatitis C is more severe in drug users with human immunodeficiency virus infection. J Viral Hepat (4):297-301, 2000.
  9. McCance-Katz EF. Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: The importance of drug interactions between opioids and antiretroviral agents. Clin Infect Dis 41:S89-96, 2005.
  10. Dukers NH, Goudsmit J, de Wit JB, Prins M, Weverling GJ, Coutinho RA. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS 15(3):369-378, 2001.
  11. Vanable PA, Ostrow DG, McKirnan DJ, Taywaditep KJ, Hope BA. Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men. Health Psychol 19(2):134-145, 2000.
  12. Boily MC, Bastos FI, Desai K, Masse B. Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: Results from mathematical models. Sex Transm Dis 31(2):100-113, 2004.
  13. Tun W, Celentano DD, Vlahov D, Strathdee SA. Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS 17(13):1953-1962, 2003.
  14. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2004 16:12, CDC, 2005. Disponible en la página: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/index.htm.
  15. Morbidity and Mortality Weekly Report (MMWR). "Trends in HIV-AIDS diagnosis-33 States 2001-2004" 54(45):1149-1153, CDC, 2005. Disponible en la página: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5445a1.htm.
  16. Centers for Disease Control and Prevention. "HIV/AIDS Surveillance in Adolescents, L265 Slide Series," CDC, 2003. Disponible en la página: http://www.cdc.gov/hiv/topics/surveillance/resources/slides/adolescents/index.htm.
  17. Anderson RN, Smith BL. Deaths: Leading causes for 2001. Natl Vit Stat Rep 52(9):27-33, 2002.
  18. Office of Applied Studies. Results from the 2004 National Survey on Drug Use and Health: National Findings (NSDUH Series H-28). DHHS Pub. No. (SMA) 05-4062. SAMHSA, 2005.
  19. Lightfoot M, Swendeman D, Rotheram-Borus MJ, Comulada WS, Weiss R. Risk behaviors of youth living with HIV: Pre- and post-HAART. Am J Health Beh 29(2):162-171, 2005.
  20. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep 113 Suppl 1:97-106, 1998.
  21. Shroeder JR, Epstein DH, Umbricht A, Preston KL. Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence. Addict Behav Aug. 5, 2005.
  22. Reback CJ, Larkins S, Shoptaw S. Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS Behav 8(1):87-98, 2004.
  23. National Institute on Drug Abuse. Principles of HIV Prevention in Drug-Using Populations: A Research-Based Guide, NIH Pub. No. 02-4733, 2002.
  24. Flay BR, Gramlich S, Segawa E, Burns JL, Holliday MY. Effects of two prevention programs on high risk behaviors among African-American youth. Arch Pediatr Adolesc Med 158(4):337-384, 2004.
  25. Sanders GD, Bayoumi AM, Sundaaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 352(6):570-585, 2005.
  26. Paltiel DA, Weinstein MC, Kimmel AD, Seage GR, Losina E, Hong Zhang SM, Freedberg KA, Walensky RP. Expanded Screening for HIV in the United States—An analysis of cost effectiveness. N Engl J Med 352(6):586-595, 2005.

Página actualizada en julio del 2006

Get this Publication

Serie de reportes de investigación

Esta serie de reportes, dirigida al público en general, los legisladores, los grupos educativos y los profesionales de la salud, explica la ciencia detrás de los resultados de la investigación.  La serie informa sobre los resultados de las investigaciones de interés nacional.

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas